Startups

UMB BioPark biotech company Noxilizer expands to Europe

The company "manufactures sterilization technology for medical devices and equipment."

Noxilizer CEO Lawrence Bruder, left, with Maryland Governor Martin O'Malley. Photo courtesy of the UMB Elm.

Biotech company Noxilizer, based out of the University of Maryland BioPark, has set up a sales operation in Europe.
The company, which “manufactures sterilization technology for medical devices and equipment,” announced in a press release that its expansion to Europe “is intended to accelerate the global acceptance of nitrogen dioxide sterilization as a powerful, efficient, and cost-saving alternative to traditional sterilization methods.”
Read more at Noxilizer.

Companies: University of Maryland BioPark
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Donate to the Journalism Fund

Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.

Trending

National AI safety group and CHIPS for America at risk with latest Trump administration firings

How women can succeed in male-dominated trades like robotics, according to one worker who’s done it

Geomapping goes splat: The evolving future of Google Earth

Northern Virginia firm’s bet on workplace culture pays off with an acquisition

Technically Media